| 12/06/25 | GSK | 11:00:00 | 12 Jun 2025 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 25/05/22 | GSK | 15:41:00 | 25 May 2022 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 01/12/21 | GSK | 11:05:00 | 1 Dec 2021 | | GSK | Total Voting Rights | GSK plc | PRN |
| 13/01/21 | | 13:45:19 | 13 Jan 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/01/21 | | 11:05:08 | 11 Jan 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/01/21 | | 09:16:23 | 11 Jan 2021 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 04/01/21 | | 11:25:51 | 4 Jan 2021 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 30/12/20 | | 11:52:48 | 30 Dec 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 23/12/20 | | 14:44:58 | 23 Dec 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 21/12/20 | | 07:00:07 | 21 Dec 2020 | | | ViiV first long-acting HIV regimen approved in EU | GlaxoSmithKline PLC | RNS |
| 11/12/20 | | 07:00:05 | 11 Dec 2020 | | | Sanofi/ GSK update on COVID vaccine candidate | GlaxoSmithKline PLC | RNS |
| 10/12/20 | | 17:51:29 | 10 Dec 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/12/20 | | 11:55:37 | 10 Dec 2020 | | | Block Listing Application | GlaxoSmithKline PLC | RNS |
| 09/12/20 | | 15:04:06 | 9 Dec 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 03/12/20 | | 17:53:35 | 3 Dec 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/12/20 | | 15:00:07 | 1 Dec 2020 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 27/11/20 | | 14:58:03 | 27 Nov 2020 | | | GSK publishes provisional 2021 dividend dates | GlaxoSmithKline PLC | RNS |
| 26/11/20 | | 12:35:27 | 26 Nov 2020 | | | EMTN Supplementary Prospectus | GlaxoSmithKline PLC | RNS |
| 25/11/20 | | 10:26:51 | 25 Nov 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 23/11/20 | | 08:59:27 | 23 Nov 2020 | | | Block listing Interim Review | GlaxoSmithKline PLC | RNS |
| 19/11/20 | | 17:40:27 | 19 Nov 2020 | | | Holding(s) in Company | GlaxoSmithKline PLC | RNS |
| 17/11/20 | | 17:48:04 | 17 Nov 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/11/20 | | 13:00:04 | 12 Nov 2020 | | | Medicago GSK phase 2/3 study start | GlaxoSmithKline PLC | RNS |
| 11/11/20 | | 15:08:55 | 11 Nov 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/11/20 | | 11:13:28 | 11 Nov 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 09/11/20 | | 07:00:12 | 9 Nov 2020 | | | ViiV’s cabotegravir superior for HIV prevention | GlaxoSmithKline PLC | RNS |
| 04/11/20 | | 17:32:04 | 4 Nov 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 04/11/20 | | 16:45:19 | 4 Nov 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 03/11/20 | | 16:09:24 | 3 Nov 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 03/11/20 | | 08:00:05 | 3 Nov 2020 | | | GSK sets new environmental goals | GlaxoSmithKline PLC | RNS |
| 02/11/20 | | 17:16:25 | 2 Nov 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 02/11/20 | | 15:59:04 | 2 Nov 2020 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 30/10/20 | | 17:08:16 | 30 Oct 2020 | | | Holding(s) in Company | GlaxoSmithKline PLC | RNS |
| 30/10/20 | | 12:53:17 | 30 Oct 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 28/10/20 | | 17:46:51 | 28 Oct 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 28/10/20 | | 12:00:04 | 28 Oct 2020 | | | 3rd Quarter Results | GlaxoSmithKline PLC | RNS |
| 28/10/20 | | 07:00:02 | 28 Oct 2020 | | | Sanofi and GSK support COVAX - 200m vaccine doses | GlaxoSmithKline PLC | RNS |
| 22/10/20 | | 12:34:49 | 22 Oct 2020 | | | Holding(s) in Company | GlaxoSmithKline PLC | RNS |
| 16/10/20 | | 12:18:52 | 16 Oct 2020 | | | Positive CHMP opinion ViiV long-acting HIV regimen | GlaxoSmithKline PLC | RNS |
| 14/10/20 | | 15:30:30 | 14 Oct 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 14/10/20 | | 15:29:30 | 14 Oct 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 13/10/20 | | 14:41:33 | 13 Oct 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 13/10/20 | | 14:08:52 | 13 Oct 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 13/10/20 | | 14:01:55 | 13 Oct 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 13/10/20 | | 13:55:43 | 13 Oct 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 13/10/20 | | 13:49:40 | 13 Oct 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 01/10/20 | | 16:30:01 | 1 Oct 2020 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 22/09/20 | | 17:42:13 | 22 Sept 2020 | | | Sanofi/GSK agree up to 72m Canada COVID doses | GlaxoSmithKline PLC | RNS |
| 11/09/20 | | 15:17:54 | 11 Sept 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/09/20 | | 10:01:59 | 10 Sept 2020 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
